| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/03/2011 | US20110052647 Antidepressant Oral Pharmaceutical Compositions |
| 03/03/2011 | US20110052646 Polymer adhesive film for directed cellular growth |
| 03/03/2011 | US20110052645 Manufacture of multiple minicapsules |
| 03/03/2011 | US20110052506 Stable Aerosol Topical Foams Comprising a Hypochlorite Salt |
| 03/03/2011 | US20110052505 Post-biopsy cavity treatment implants and methods |
| 03/03/2011 | US20110052496 Hollow nanoparticles and uses thereof |
| 03/03/2011 | US20110052493 Use of polypeptides obtained through systematic mutations of single amino acids of human and non-human box-a of hmgb1 to prevent and/or antagonize pathologies induced by hmgb1 |
| 03/03/2011 | US20110049737 Device, method and use for the formation of small particles |
| 03/03/2011 | CA2772566A1 Pulsatile release of medicaments from a punctal plug |
| 03/03/2011 | CA2772301A1 Combination therapy with nanoparticle compositions of taxane and hedgehog inhibitors |
| 03/03/2011 | CA2770695A1 Synthesis of oxygen carrying, turbulence resistant, high density submicron particulates |
| 03/03/2011 | CA2770212A1 Film coating composition from solid powder compounds |
| 03/03/2011 | CA2769872A1 New compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine |
| 03/03/2011 | CA2768651A1 Particulate composition and pharmaceutical composition containing the same |
| 03/02/2011 | EP2289970A1 Biocompatible polymers, their process of manufacture and compositions containing them |
| 03/02/2011 | EP2289939A2 PAN-KIR2DL NK-receptor antibodies and their use in diagnostik and therapy |
| 03/02/2011 | EP2289911A2 Therapeutic use of a growth factor, NsG33 |
| 03/02/2011 | EP2289660A1 Device and process of cutting TDS and ODF materials with two pairs of advancing rolls |
| 03/02/2011 | EP2289566A1 Medical device comprising a haemostatic agent and haemostatic kit comprising the medical device |
| 03/02/2011 | EP2289561A1 Method for preparing molecular complexes |
| 03/02/2011 | EP2289557A1 Pharmaceutical compositions comprising peranhydrocyclodextrine |
| 03/02/2011 | EP2289556A2 Pharmaceutical composition for use in treatment of diabetes |
| 03/02/2011 | EP2289539A1 Zinc-free and low-zinc insulin preparations with improved stability |
| 03/02/2011 | EP2289529A1 Nigella extracts for the treatment of disorders connected to impaired or imbalanced neurotransmission |
| 03/02/2011 | EP2289517A2 Controlled release oxycodone compositions |
| 03/02/2011 | EP2289514A1 Pramipexole once daily dosage form |
| 03/02/2011 | EP2289512A1 Pharmaceutical foam |
| 03/02/2011 | EP2289506A2 Medicament comprising a C11-C21 alkanoic, alkenoic or alkynoic acid ester and a catechin |
| 03/02/2011 | EP2289503A2 Treating muscle wasting with selective androgen receptor modulators |
| 03/02/2011 | EP2289497A1 Once-daily administration of central nervous system drugs |
| 03/02/2011 | EP2289496A2 Non-gelatin soft capsule system |
| 03/02/2011 | EP2289495A1 Polysaccharide capsules and methods of preparation |
| 03/02/2011 | EP2289494A1 Polysaccharide capsules and methods of preparation |
| 03/02/2011 | EP2289493A1 Solid naproxen concentrates and related dosage forms |
| 03/02/2011 | EP2289492A2 Naltrexone hydrochloride compositions |
| 03/02/2011 | EP2289491A1 Alcohol resistant dosage forms |
| 03/02/2011 | EP2289490A1 Charged lipoprotein complexes and their uses |
| 03/02/2011 | EP2289489A2 Compositions comprising cyclohexylamines and aminoadamantanes |
| 03/02/2011 | EP2289488A2 Remedies for diseases to be applied to eye |
| 03/02/2011 | EP2289487A1 Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof |
| 03/02/2011 | EP2289486A1 Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof |
| 03/02/2011 | EP2289470A1 Expandable medical advice |
| 03/02/2011 | EP2288396A2 Stimulation of cartilage formation using reduced pressure treatment and chondrocytes |
| 03/02/2011 | EP2288369A1 Compositions of gnrh related compounds and processes of preparation |
| 03/02/2011 | EP2288353A2 Method for treating acute pain with a formulated drug depot in combination with a liquid formulation |
| 03/02/2011 | EP2288352A2 Clonidine formulation in a polyorthoester carrier |
| 03/02/2011 | EP2288344A1 A transdermal drug delivery device |
| 03/02/2011 | EP2288343A1 Nitric oxide-releasing compositions, devices and methods |
| 03/02/2011 | EP2288342A1 Magnesium system and use thereof in the cosmetics industry |
| 03/02/2011 | EP2288341A1 Use of a matrix for orally administering sustained release magnesium, and composition containing said matrix |
| 03/02/2011 | EP2288340A1 Nanoparticle formulations and uses thereof |
| 03/02/2011 | EP2288339A1 In situ gelling systems as sustained delivery for front of eye |
| 03/02/2011 | EP2288338A1 Stable pharmaceutical formulations |
| 03/02/2011 | EP2288337A1 Parenteral supplement with traceelem ntsfor treatment of i. a. sirs, burns selenium-defenciencies |
| 03/02/2011 | EP2288336A2 Nanostructures suitable for sequestering cholesterol |
| 03/02/2011 | EP2288335A1 Process for preparing orally administered dabigatran formulations |
| 03/02/2011 | EP2288334A1 Composition and method for transmucosal delivery of lofexidine |
| 03/02/2011 | EP2288258A1 Inhibition of neovascularization by cerium oxide nanoparticles |
| 03/02/2011 | EP2178511B1 Tableted compositions containing atazanavir |
| 03/02/2011 | EP1763340B1 Rapidly dispersible, fine-grained, separation-resistant pulverulent film coating agent, based on polyvinyl alcohol-polyether graft copolymers and characterised by a particular physical stability and a low degree of roughness |
| 03/02/2011 | EP1650225B1 Hetero type pentamer recombinant vaccine |
| 03/02/2011 | EP1511489B1 New pharmaceutical compositions containing flibanserin polymorph a |
| 03/02/2011 | EP1423101B1 Use of a plaster for the treatment of onychomycoses |
| 03/02/2011 | EP1417975B1 Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient |
| 03/02/2011 | EP1261427B1 Microfabricated devices and methods for storage and selective exposure of chemicals |
| 03/02/2011 | EP1248613B1 Clonidine preparations |
| 03/02/2011 | EP1064942B9 Sustained release preparation of a macrolide |
| 03/02/2011 | CN201752501U Shenchai Gankang soft capsule |
| 03/02/2011 | CN101983075A Adhesive preparation for external use |
| 03/02/2011 | CN101983055A Method for production of orally rapidly disintegrating tablet comprising imidafenacin as active ingredient |
| 03/02/2011 | CN101983054A Orally rapidly disintegrating tablet comprising imidafenacin |
| 03/02/2011 | CN101983052A Galenic form for the oral transmucosal delivery of triptans |
| 03/02/2011 | CN101982200A Rhizoma coptidis total alkaloids resin complexes, sustained-release preparation thereof and preparation method thereof |
| 03/02/2011 | CN101982199A Compositions containing acid-unstable physiologically active compounds and process for producing the same |
| 03/02/2011 | CN101982198A Perfusion medicinal oil for treating hysteritis of cow and preparation method thereof |
| 03/02/2011 | CN101982197A Plukenetia volubilis polypeptide oral liquid |
| 03/02/2011 | CN101982195A Medicine for treating rheumatoid arthritis pain and preparation method thereof |
| 03/02/2011 | CN101982190A External cream for treating wind cold by utilizing percutaneous absorption technology |
| 03/02/2011 | CN101982189A Method for detecting salvia heart-soothing capsules |
| 03/02/2011 | CN101982180A Novel probiotic viable bacteria vaginal suppository body |
| 03/02/2011 | CN101982179A Xiao er Anfen Huang Namin granule and preparation method thereof |
| 03/02/2011 | CN101982177A Flexible nano realgar liposome as well as preparation method and application thereof |
| 03/02/2011 | CN101982176A Compound sodium selenite-vitamin E oral nano-emulsion preparation for livestock and preparation method thereof |
| 03/02/2011 | CN101982173A Danofloxacin mesylate-amoxicillinsuspension injection applicable to livestock and poultry as well as preparation and application thereof |
| 03/02/2011 | CN101982169A Novel external non-plaster patch |
| 03/02/2011 | CN101982168A Quercetin nano-micelle preparation and preparation method thereof |
| 03/02/2011 | CN101982167A Butoconazole nitrate suppository used in gynaecology, preparation method and application thereof |
| 03/02/2011 | CN101982166A Slow release formulation of moxifloxacin and preparation method thereof |
| 03/02/2011 | CN101385827B Sea cucumber health paste and production method thereof |
| 03/02/2011 | CN101352481B Method for preparing Chinese medicine desmodium anti-calculi fractionated extracts and uses thereof |
| 03/02/2011 | CN101342199B Chinese ephedra prescription particle, preparation method and quality control method thereof |
| 03/02/2011 | CN101322709B Medicament composition containing aripiprazole and preparation thereof |
| 03/02/2011 | CN101278907B Coenzyme Q10 injection |
| 03/02/2011 | CN101185649B Levoleucovorin freeze-dried injection agent and preparation method and pharmaceutical use thereof |
| 03/02/2011 | CN101099758B Compound gingko leaves preparation and its preparing process |
| 03/02/2011 | CN101084889B Ginkgolide freezing-dried powder injection and preparation method thereof |
| 03/01/2011 | US7897728 Hydrolyzing gelatin by contacting a gelatine with one or more proteolytic enzyme having endopeptidase activity and contacting the product with one or more proteolytic enzymes having exopeptidase activity; average viscosity of 10 to 15 cP; improved crosslinking and dissolution properties. |
| 03/01/2011 | US7897646 Use for budesonide and formoterol |
| 03/01/2011 | US7897586 Veterinary medicine; aqueous solution containing cyclodextrins |
| 03/01/2011 | US7897564 Flowable carrier matrix and methods for delivering to a patient |